Axogen Inc vs iShares MSCI South Korea ETF — how do they compare? Axogen Inc trades at $38.5 (market cap $2.06B), while iShares MSCI South Korea ETF trades at $174.71. Which is the better fit depends on your goals.
| AXGN | EWY | |
|---|---|---|
Market Cap | $2.06B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $46.19 | $219.20 |
52-Week Low | $11.28 | $70.65 |
Enterprise Value | $1.98B | — |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
EWY, the iShares MSCI South Korea ETF, trades at $168.08, down 8.41% over 24 hours amid a bearish technical signal. The ETF is heavily concentrated in Samsung and SK Hynix, exposing it to volatility in AI-driven semiconductor demand. Recent news highlights South Korean market turbulence, with the Kospi Index experiencing sharp declines and recoveries tied to chip stock performance. Key support lies at $162, with resistance at $171. Financial ratios are unavailable in the provided data, limiting fundamental clarity.
The outlook for EWY hinges on semiconductor cycle dynamics and foreign investor sentiment. Opportunities exist if AI memory demand rebounds, but risks include high concentration in two stocks, global tech volatility, and macroeconomic pressures. The bearish technical trend and neutral oscillators suggest cautious near-term momentum, requiring monitoring of earnings from top holdings for directional cues.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →EWY tracks the MSCI Korea 25/50 Index, offering targeted exposure to large and mid-cap companies in South Korea. It is structurally centered on the global technology supply chain, industrials, and financial services, serving as a liquid tool for investors seeking a single-country view of this advanced, innovation-led economy.
Read more on EWY →